Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5219
DC Field | Value | Language |
---|---|---|
dc.contributor.author | El Hachem, Georges | en_US |
dc.contributor.author | Gombos, Andrea | en_US |
dc.contributor.author | Awada, Ahmad | en_US |
dc.date.accessioned | 2021-12-09T09:34:57Z | - |
dc.date.available | 2021-12-09T09:34:57Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 14737140 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/5219 | - |
dc.description.abstract | The field of metastatic luminal breast cancer (hormone receptor positive, HER-2 negative) is dynamic and evolving, harboring some of the most significant therapeutic advances in medical oncology. Over the last decade, many pivotal trials showed excellent results with drastic improvements in survival as well as the quality of life of metastatic luminal breast cancer patients. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Taylor & Francis Online | en_US |
dc.subject | CDK 4/6 inhibitors | en_US |
dc.subject | Luminal breast cancer | en_US |
dc.subject | Abemaciclib | en_US |
dc.subject | Brain metastases | en_US |
dc.subject | Hormone receptor positive | en_US |
dc.title | Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1080/14737140.2020.1834385 | - |
dc.identifier.pmid | 33054442 | - |
dc.identifier.scopus | 2-s2.0-85097407790 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85097407790 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.description.volume | 21 | en_US |
dc.description.issue | 1 | en_US |
dc.description.startpage | 81 | en_US |
dc.description.endpage | 92 | en_US |
dc.date.catalogued | 2021-12-09 | - |
dc.description.status | Published | en_US |
dc.identifier.ezproxyURL | http://ezsecureaccess.balamand.edu.lb/login?url=https://www.tandfonline.com/doi/full/10.1080/14737140.2020.1834385 | en_US |
dc.relation.ispartoftext | Expert Review of Anticancer Therapy | en_US |
dc.description.campus | SGH campus | en_US |
Appears in Collections: | Faculty of Medicine |
SCOPUSTM
Citations
8
checked on Nov 16, 2024
Record view(s)
71
checked on Nov 22, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.